Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
GCC FABRY DISEASE Competitive Intelligence
GCC FABRY DISEASE Competitive Intelligence
Migalastat is covered for 35-50% of GCC Fabry patients with an amenable mutation, but fewer than 15% have been tested.
Classic Fabry disease prevalence in GCC is...
